Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests: 2018-2021

Historic Income from Non-Controlling Interests for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Dec 2021 value amounting to $1.2 million.

  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests fell 261.56% to -$1.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$92,000, marking a year-over-year decrease of 101.00%. This contributed to the annual value of $1.2 million for FY2021, which is 287.25% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Income from Non-Controlling Interests of $1.2 million as of FY2021, which was up 287.25% from $306,000 recorded in FY2020.
  • In the past 5 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests registered a high of $2.4 million during FY2019, and its lowest value of -$922,000 during FY2018.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was $1.2 million (2021), whereas its average is $1.3 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests surged by 363.99% in 2019 and then tumbled by 87.43% in 2020.
  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests (Yearly) stood at -$922,000 in 2018, then spiked by 363.99% to $2.4 million in 2019, then tumbled by 87.43% to $306,000 in 2020, then soared by 287.25% to $1.2 million in 2021.